Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
103
天
Alkylating agents activate an SLFN11-dependent vulnerability that confers PARP-1 inhibitor sensitivity in kidney cancer
作者
Chenliang Wang; Ming Zhu; Lei Bao; Vanina Toffessi Tcheuyap; James Brugarolas; Weibo Luo; Yingfei Wang展开收起
作者单位
1. Department of Pathology, UT Southwestern Medical Center, Dallas, USA; 2. Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, USA; 3. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, USA; 4. Department of Pharmacology, UT Southwestern Medical Center, Dallas, USA; 5. Department of Neurology, UT Southwestern Medical Center, Dallas, USA; 6. Peter O’Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, USA展开收起
81
天
NOTCH3 regulates myofibroblastic CAF differentiation via the P62–ROS signaling axis to promote bladder cancer progression
作者
Ding Hu; Chengquan Shen; Changxue Liu; Fei Xie; Xinning Wang; Hexiang Wang; Yunqing Chen; Xinzhao Zhao; Ruize Qin; Cheng Li; Huaixi Ge; Jianhang Zhu; Zhengze Xi; Yonghua Wang展开收起
作者单位
1. Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China; 2. Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China; 3. Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China; 4. Urinary Diseases Clinical Medical Research Center of Qingdao, Qingdao, China; 5. Shandong Province Medical and Health Key Laboratory of Urology, Qingdao, China展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
